Decoding the Immune Response Behind Moderna’s Personalized mRNA Cancer Vaccine
Wed, Mar 17
|
04:00 PM - 04:20 PM
Track 1
Session details:
Translational immunology behind Moderna’s personalized mRNA cancer vaccine, including vaccine-induced immune responses, biomarkers of activity, and insights into how this approach may overcome limitations of prior cancer vaccine strategies.